Journal article
Economic Evaluation of Caffeine for Apnea of Prematurity
Abstract
OBJECTIVE: To determine the cost-effectiveness of treatment with caffeine compared with placebo for apnea of prematurity in infants with birth weights less than 1250 g, from birth through 18 to 21 months' corrected age.
METHODS: We undertook a retrospective economic evaluation of the cost per survivor without neurodevelopmental impairment by using individual-patient data from the Caffeine for Apnea of Prematurity clinical trial (N = 1869). We …
Authors
Dukhovny D; Lorch SA; Schmidt B; Doyle LW; Kok JH; Roberts RS; Kamholz KL; Wang N; Mao W; Zupancic JAF
Journal
, Vol. 127, No. 1, pp. e146–e155
Publisher
American Academy of Pediatrics (AAP)
Publication Date
January 1, 2011
DOI
10.1542/peds.2010-1014
ISSN
0031-4005